KPT-8602 (eltanexor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KPT-8602 (eltanexor), covering 2025-03-19 to 2025-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications [Phase 1, Phase 2]